Those are lots of great links from August and September. None of them imply anything other than LL is not an antiviral, but an immune-modulator.
Wouldn't you agree, that Leronlimab would be wasted in the early, viral stages of Sars-CoV-2 infection? And more useful in the immune-deficient stages of the Covid-19 disease?